Field & Main Bank Purchases Shares of 19,053 Merck KGaA $MKGAF

Field & Main Bank acquired a new position in Merck KGaA (OTCMKTS:MKGAF) during the second quarter, Holdings Channel reports. The firm acquired 19,053 shares of the company’s stock, valued at approximately $2,448,000.

Other large investors have also bought and sold shares of the company. Prosperitas Financial LLC acquired a new position in Merck KGaA during the second quarter worth about $364,000. Archer Investment Corp bought a new stake in Merck KGaA in the second quarter worth about $2,757,000. Kingsview Wealth Management LLC acquired a new stake in Merck KGaA in the 2nd quarter valued at about $10,337,000. Henson Edgewater Management LLC bought a new position in shares of Merck KGaA during the 2nd quarter valued at about $377,000. Finally, Beacon Pointe Advisors LLC bought a new position in shares of Merck KGaA during the 2nd quarter valued at about $46,655,000. Institutional investors own 0.10% of the company’s stock.

Merck KGaA Stock Performance

Shares of MKGAF opened at $164.12 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm’s 50 day moving average is $163.35 and its 200-day moving average is $149.06. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56. The stock has a market capitalization of $21.21 billion, a P/E ratio of 25.06 and a beta of 0.96.

About Merck KGaA

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.